← Leaderboards
Darwin Leroy Cheney
Theratarget
$1,022,066
Attributed
$2,044,132
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $944.5K · FY2011–19$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,044,132 · 3
By mechanism
R42$1,495,828 · 1
R41$548,304 · 2
Top collaborators
- Hamid Ghandehari6 shared
- Jindrich N. Kopecek1 shared
Others in their field
Top investigators on “Molecular Weight”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$85,015,906
- Gregory H Reaman · National Childhood Cancer Foundation$66,019,392
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard L Schilsky · University Of Chicago$50,043,295
- Howard J Rosen · Mayo Clinic Rochester$41,912,633
- Bradley F Boeve · Mayo Clinic Rochester$35,844,426
Research focus
Molecular WeightSmall Business Technology Transfer ResearchDesignBaseIn VivoPolymersStructureIn VitroCharacteristicsAqueousLiquid SubstanceOperative Surgical ProceduresGenetic EngineeringFormulationHydrogelsChronicBlood FlowCancer CellDrug Delivery SystemsEvaluationBiological Response Modifier TherapyBiomaterial CompatibilityBloodCatheters
Grant awards (7)
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma$1,450
R42 · FY2019 · CA
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma$399,441
R42 · FY2018 · CA
Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms$150,000
R41 · FY2018 · NS
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma$694,475
R42 · FY2017 · CA
Recombinant Silk Elastin-like Protein Polymers for the Embolization of Cerebral Aneurysms$250,000
R41 · FY2017 · NS
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma$400,462
R42 · FY2016 · CA
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer$148,304
R41 · FY2011 · CA